Skip to main content

Animations

MJFF Publications

5581 - 5590 of 6403 Results
Title
Year
  • Year
  • 2022
  • 2019
  • 2019
  • 2020
  • 2017
  • 2021
  • 2019
  • 2023
  • 2022
  • 2018
  • Summary Details
    OPEN
    Title: Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-022-02488-3
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30141-3
    Citation Count: 112
  • Summary Details
    OPEN
    Title: New aspects of USP30 biology in the regulation of pexophagy
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15548627.2019.1615304
    Citation Count: 14
  • Summary Details
    OPEN
    Title: USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylation
    Journal Name: Life Science Alliance
    Publisher: Life Science Alliance, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.26508/lsa.202000768
    Citation Count: 105
  • Summary Details
    OPEN
    Title: An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant Pathways
    Journal Name: Molecular & Cellular Proteomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1074/mcp.m116.061440
    Citation Count: 70
  • Summary Details
    OPEN
    Title: CD4 + T cells contribute to neurodegeneration in Lewy body dementia
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.abf7266
    Citation Count: 200
  • Summary Details
    OPEN
    Title: Integrated proteogenetic analysis reveals the landscape of a mitochondrial-autophagosome synapse during PARK2-dependent mitophagy
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.aay4624
    Citation Count: 73
  • Summary Details
    OPEN
    Title: LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adh9543
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Endoplasmic Reticulum Membrane Contact Sites, Lipid Transport, and Neurodegeneration
    Journal Name: Cold Spring Harbor Perspectives in Biology
    Publisher: Cold Spring Harbor Laboratory
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1101/cshperspect.a041257
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddy260
    Citation Count: 53
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.